Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers

NCT06918951 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

194

Enrollment

OTHER

Sponsor class

Conditions

Oligoprogression
Oligometastatic Disease
OligoProgressive Metastatic Disease

Interventions

RADIATION: Stereotactic ablative radiotherapy (SABR)
RADIATION: Palliative radiotherapy

Sponsor

British Columbia Cancer Agency